发明名称 |
HEPATITIS C VIRUS INHIBITORS |
摘要 |
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: Q-G-A-L-B—Z—W  (I), which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. |
申请公布号 |
EP2768517(A2) |
申请公布日期 |
2014.08.27 |
申请号 |
EP20120842339 |
申请日期 |
2012.10.17 |
申请人 |
ENANTA PHARMACEUTICALS, INC. |
发明人 |
QIU, YAO-LING;CAO, HUI;PENG, XIAOWEN;CHEN, ZHIGANG;OR, YAT, SUN |
分类号 |
A61K38/12 |
主分类号 |
A61K38/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|